Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Germany · Delayed Price · Currency is EUR 0.9650
+0.0050 (0.52%)
Aug 5, 2026, 5:35 PM CET
ETR:MAK Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 125.58 | 123.46 | 114.94 | 114.29 | 119.65 | |
Revenue Growth | 1.72% | 7.41% | 0.57% | -4.49% | 1.20% |
Cost of Revenue | -94.99 | -89.54 | 90.4 | 90.27 | 82.66 |
Gross Profit | 220.58 | 213 | 24.53 | 24.02 | 37 |
Selling, General & Admin | -26.71 | -23.65 | 20.08 | 22.36 | 22.12 |
Depreciation & Amortization Expenses | -8.82 | -12.56 | 9.75 | 11.02 | 11.12 |
Total Operating Expenses | -35.52 | -36.21 | 29.83 | 33.37 | 33.23 |
Operating Income | 256.1 | 249.21 | -5.29 | -9.35 | 3.76 |
Interest Income | 0.08 | 0.38 | 0.16 | 0.05 | 0.08 |
Interest Expense | 8.02 | 8.43 | -7.55 | -5.78 | -6.01 |
Other Non-Operating Income (Expense) | 0.11 | 0.06 | 0.11 | 2.25 | - |
Total Non-Operating Income (Expense) | 8.21 | 8.87 | -7.29 | -3.47 | -5.93 |
Pretax Income | -12.76 | -10.28 | -12.58 | -12.83 | -2.04 |
Provision for Income Taxes | 1.1 | 2.88 | 1.67 | -1.25 | -0.52 |
Net Income | -13.85 | -13.16 | -14.26 | -14.08 | -2.56 |
Minority Interest in Earnings | - | - | - | - | 0.13 |
Net Income to Common | -13.85 | -13.16 | -14.26 | -14.08 | -2.56 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 |
Shares Change | - | - | - | - | - |
EPS (Basic) | -0.66 | -0.63 | -0.68 | -0.67 | -0.12 |
EPS (Diluted) | -0.66 | -0.63 | -0.68 | -0.67 | -0.12 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 11.16 | 13.86 | -1.44 | 2.33 | 15.33 |
Free Cash Flow Growth | -19.45% | - | - | -84.78% | 33.86% |
Free Cash Flow Per Share | 0.53 | 0.66 | -0.07 | 0.11 | 0.73 |
Gross Margin | 175.64% | 172.53% | 21.35% | 21.02% | 30.92% |
Operating Margin | 203.93% | 201.85% | -4.61% | -8.18% | 3.14% |
Profit Margin | -11.03% | -10.66% | -12.40% | -12.32% | -2.14% |
FCF Margin | 8.89% | 11.22% | -1.25% | 2.04% | 12.82% |
EBITDA | 264.91 | 261.76 | 4.45 | 1.66 | 14.88 |
EBITDA Margin | 210.95% | 212.02% | 3.87% | 1.46% | 12.44% |
EBIT | 256.1 | 249.21 | -5.29 | -9.35 | 3.76 |
EBIT Margin | 203.93% | 201.85% | -4.61% | -8.18% | 3.14% |
Effective Tax Rate | -8.58% | -28.05% | -13.30% | 9.75% | 25.54% |